hypeless
Back to the news

Companies

Zydus Lifesciences, Granules India offer growth opportunities over next 3-5 years: Shanika Capital

Reported by: CNBC TV18 ·

WhatsApp

Zydus LifesciencesGranules India

Summary

CNBC TV18 published an analyst's view from Shanika Capital, where Anmol Ganjoo named Zydus Lifesciences and Granules India as pharma companies with growth opportunities over the next three to five years. The outlet said the view rests on earnings growth, capital allocation and future opportunities. Earnings growth means profit rising over time; capital allocation is how a company spends its money, on factories, research or debt. The report gives no figures, targets or dates beyond the three-to-five-year horizon. This is the analyst's view, not Hypeless's.

AI summary of what CNBC TV18 reported. AI can make mistakes. Read the full story on CNBC TV18

Sources

Every outlet that reported this story. Each link opens the outlet's own article.

What each outlet wrote

The same news, in each outlet's own headline. Open one to read their full story.

CNBC TV18  · · Tone +1

Zydus Lifesciences, Granules India offer growth opportunities over next 3-5 years: Shanika Capital

Shanika Capital's Anmol Ganjoo identifies Zydus Lifesciences and Granules India as potential pharma winners, citing earnings growth, capital allocation and future opportunities.

Some headlines quote an analyst. Those views are theirs, not ours.

Key terms

Words in this story, explained in plain language in our Learn pages.

  • earnings

    Revenue, profit, margins and EPS: what the numbers in a quarterly result mean, why year-on-year and quarter-on-quarter differ, and what a headline can leave out.

    Learn: How to read a company's results

  • future

    Futures and options (F&O) are contracts based on a share or index. Learn what they are, why leverage cuts both ways, and what SEBI's own study found about individual traders.

    Learn: F&O, and why most individual traders lose

Earlier coverage

What outlets reported about the same company before this story, newest first.

Ask Hypeless about this story

Ask what it means, what a term in it means, or what other outlets said. Answers use only these outlets' headlines.

Ask Hypeless